Pharma TV Transparency Report
Find out how top pharma brands are adapting to the state of linear TV viewership—revealing the programs, networks, ad formats, and creative elements driving the highest results.
Traditional TV audiences are aging, and overall linear TV viewership is on the decline. But pharma brands are bucking the trend—expanding their TV ad presence and increasing spend as new Rx drugs hit the market and connect with key audiences. Meanwhile, some brands are making waves by navigating streaming as a critical component of their media mix.
This report uncovers how top brands are reaching the right viewers through targeted placements on news programs, daytime TV, and major events like the Olympics. But it’s not just about where you advertise—it’s about how. From ad length and regulatory messaging to celebrity endorsements, we reveal the creative elements driving high-impact performance for pharma ads.
Download the full report now to discover the media strategies fueling billions in TV ad spend.
Inside the Report
- Which program boosted pharma ad impressions by 68% and why it’s leading the pack.
- Insights on 15- vs. 60-second ads—which format captures the most engagement.
- The top TV programs driving 54.2 billion ad impressions for prescription drug brands.
- What percentage of ad time is spent on regulatory messaging, its impact on engagement, and how to avoid the drop-off.
- Which celebrity endorsement is moving the needle for one pharma brand.
- How treatments for depression, bipolar, and insomnia vary in streaming vs. linear SOV.